Literature DB >> 11119485

Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae.

I Ofek1, A Mesika, M Kalina, Y Keisari, R Podschun, H Sahly, D Chang, D McGregor, E Crouch.   

Abstract

Pulmonary surfactant protein D (SP-D) is a collagenous C-type lectin (collectin) that is secreted into the alveoli and distal airways of the lung. We have studied the interactions of SP-D and alveolar macrophages with Klebsiella pneumoniae, a common cause of nosocomial pneumonia. SP-D does not agglutinate encapsulated K. pneumoniae but selectively agglutinates spontaneous, unencapsulated phase variants, such as Klebsiella strain K50-3OF, through interactions with their lipopolysaccharides (LPS). These effects are calcium dependent and inhibited with maltose but not lactose, consistent with involvement of the SP-D carbohydrate recognition domain. Precoating of K50-3OF with SP-D enhances the phagocytosis and killing of these organisms by rat alveolar macrophages in cell culture and stimulates the production of nitric oxide by the NR-8383 rat alveolar macrophage cell line. SP-D similarly enhances the NO response to K50-3OF LPS adsorbed to Latex beads under conditions where soluble LPS or SP-D, or soluble complexes of SP-D and LPS, do not stimulate NO production. Our studies demonstrate that interactions of SP-D with exposed arrays of Klebsiella LPS on a particulate surface can enhance the host defense activities of alveolar macrophages and suggest that activation of macrophages by SP-D requires binding to microorganisms or other particulate ligands. Because unencapsulated phase variants are likely to be responsible for the initial stages of tissue invasion and infection, we speculate that SP-D-mediated agglutination and/or opsonization of K. pneumoniae is an important defense mechanism for this respiratory pathogen in otherwise healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119485      PMCID: PMC97851          DOI: 10.1128/IAI.69.1.24-33.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

Review 1.  Potential role of surfactant proteins A and D in innate lung defense against pathogens.

Authors:  L M van Golde
Journal:  Biol Neonate       Date:  1995

2.  Bacterial adhesion measured by growth of adherent organisms.

Authors:  E V Sokurenko; V A McMackin; D L Hasty
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili.

Authors:  I Ofek; E H Beachey; A L Bisno
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

4.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly.

Authors:  E Crouch; D Chang; K Rust; A Persson; J Heuser
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

6.  Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae.

Authors:  P Domenico; R J Salo; A S Cross; B A Cunha
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.

Authors:  H Sahly; J Kekow; R Podschun; M Schaff; W L Gross; U Ullmann
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.

Authors:  D M O'Riordan; J E Standing; K Y Kwon; D Chang; E C Crouch; A H Limper
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 9.  Regulation of nitric oxide synthesis in infectious and autoimmune diseases.

Authors:  F Y Liew
Journal:  Immunol Lett       Date:  1994-12       Impact factor: 3.685

10.  Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.

Authors:  J C Pikaar; W F Voorhout; L M van Golde; J Verhoef; J A Van Strijp; J F van Iwaarden
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  41 in total

1.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

2.  Acute hypoxia decreases E. coli LPS-induced cytokine production and NF-kappaB activation in alveolar macrophages.

Authors:  George M Matuschak; Ravi Nayak; Timothy M Doyle; Andrew J Lechner
Journal:  Respir Physiol Neurobiol       Date:  2010-05-12       Impact factor: 1.931

3.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

4.  Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice.

Authors:  Jennifer M Dolan; Jason B Weinberg; Edmund O'Brien; Anya Abashian; Megan C Procario; David M Aronoff; Leslie J Crofford; Marc Peters-Golden; Lindsay Ward; Peter Mancuso
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-08       Impact factor: 5.464

5.  Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D.

Authors:  Elena Kostina; Itzhak Ofek; Erika Crouch; Rotem Friedman; Lea Sirota; Gil Klinger; Hany Sahly; Yona Keisari
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Mature Surfactant Protein-B Expression by Immunohistochemistry as a Marker for Surfactant System Development in the Fetal Sheep Lung.

Authors:  Mitchell C Lock; Erin V McGillick; Sandra Orgeig; Song Zhang; I Caroline McMillen; Janna L Morrison
Journal:  J Histochem Cytochem       Date:  2015-08-21       Impact factor: 2.479

7.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

9.  Effect of nebulized bovine surfactant for experimental otitis media with effusion.

Authors:  Chul Ho Jang; Yong Bum Cho; Seung Eun Oh; Jeong Uk Choi; Haekyun Park; Cheol Hee Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

Review 10.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.